medmix AG

SWX:MEDX Voorraadrapport

Marktkapitalisatie: CHF 399.7m

medmix Toekomstige groei

Future criteriumcontroles 3/6

medmix is forecast to grow earnings and revenue by 59.6% and 4% per annum respectively. EPS is expected to grow by 59.4% per annum. Return on equity is forecast to be 12.6% in 3 years.

Belangrijke informatie

59.6%

Groei van de winst

59.4%

Groei van de winst per aandeel

Medical Equipment winstgroei14.7%
Inkomstengroei4.0%
Toekomstig rendement op eigen vermogen12.6%
Dekking van analisten

Low

Laatst bijgewerkt22 Jul 2024

Recente toekomstige groei-updates

Recent updates

medmix AG (VTX:MEDX) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Aug 11
medmix AG (VTX:MEDX) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

medmix (VTX:MEDX) Is Reinvesting At Lower Rates Of Return

Dec 19
medmix (VTX:MEDX) Is Reinvesting At Lower Rates Of Return

An Intrinsic Calculation For medmix AG (VTX:MEDX) Suggests It's 21% Undervalued

Oct 27
An Intrinsic Calculation For medmix AG (VTX:MEDX) Suggests It's 21% Undervalued

Investors Could Be Concerned With medmix's (VTX:MEDX) Returns On Capital

Aug 16
Investors Could Be Concerned With medmix's (VTX:MEDX) Returns On Capital

There May Be Reason For Hope In medmix's (VTX:MEDX) Disappointing Earnings

Feb 28
There May Be Reason For Hope In medmix's (VTX:MEDX) Disappointing Earnings

medmix (VTX:MEDX) May Have Issues Allocating Its Capital

Jan 14
medmix (VTX:MEDX) May Have Issues Allocating Its Capital

Winst- en omzetgroeiprognoses

SWX:MEDX - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CHF Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/202654033481132
12/31/202551630441062
12/31/20244912037962
6/30/2024480-21569N/A
3/31/2024483-1963N/A
12/31/20234870356N/A
9/30/20234815-347N/A
6/30/202347510-937N/A
3/31/202347611042N/A
12/31/202247712948N/A
9/30/2022478212257N/A
6/30/2022480313666N/A
3/31/2022468374676N/A
12/31/2021457445587N/A
9/30/2021435365690N/A
6/30/2021414285794N/A
3/31/2021382193272N/A
12/31/202035110851N/A
12/31/2019421255389N/A
12/31/2018454526494N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: MEDX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.3%).

Winst versus markt: MEDX is forecast to become profitable over the next 3 years, which is considered above average market growth.

Hoge groeiwinsten: MEDX is expected to become profitable in the next 3 years.

Omzet versus markt: MEDX's revenue (4% per year) is forecast to grow slower than the Swiss market (4% per year).

Hoge groei-inkomsten: MEDX's revenue (4% per year) is forecast to grow slower than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: MEDX's Return on Equity is forecast to be low in 3 years time (12.6%).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y